The Enterprise Value as of September 2024 (TTM) for Antibe Therapeutics Inc. (ATBPF) is 4.17M

According to Antibe Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.17M. This represents a change of -82.95% compared to the average of 24.43M of the last 4 quarters.

Antibe Therapeutics Inc. (ATBPF) Historical Enterprise Value (quarterly & annually)

How has ATBPF Enterprise Value performed in the past?

The mean historical Enterprise Value of Antibe Therapeutics Inc. over the last ten years is 19.56M. The current 4.17M Enterprise Value has changed 2.03% with respect to the historical average. Over the past ten years (40 quarters), ATBPF's Enterprise Value was at its highest in in the March 2021 quarter at 138.91M. The Enterprise Value was at its lowest in in the December 2021 quarter at -24705057.46.

Antibe Therapeutics Inc. (ATBPF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Antibe Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Antibe Therapeutics Inc. (ATBPF) Average Enterprise Value

How has ATBPF Enterprise Value performed in the past?

The current Enterprise Value of Antibe Therapeutics Inc. (ATBPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Antibe Therapeutics Inc. (ATBPF) Enterprise Value vs. Peers

How is ATBPF’s Enterprise Value compared to its peers?

Antibe Therapeutics Inc.’s Enterprise Value is less than Biotron Limited (14.53M), greater than Bioasis Technologies Inc. (398.28K), less than Covalon Technologies Ltd. (71.67M), less than Mosaic ImmunoEngineering Inc. (8.29M), less than Ceapro Inc. (15.55M), less than Cellectis S.A. (144.28M), less than Adynxx, Inc. (0), greater than AVAX Technologies, Inc. (87.12K), greater than BioCardia, Inc. (514.05K), less than Adial Pharmaceuticals, Inc. WT EXP 073123 (10.50M), greater than null (3.63M),

Build a custom stock screener for Antibe Therapeutics Inc. (ATBPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Antibe Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Antibe Therapeutics Inc. (ATBPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Antibe Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.